RSH 6.33% 8.4¢ respiri limited

Ann: wheezo Launch Update, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,279 Posts.
    lightbulb Created with Sketch. 1028
    alcp

    read it slowly





    Multinational pharmaceutical company Cipla Australia says several key banner groups have come onboard to sell Respiri Limited’s (ASX:RSH) wheezo wheeze-detection device, which Cipla is supplying to select pharmacies to help asthma patients better manage their conditions.
    “It is terrific to see a product like wheezo now available,” says Azhar Ibrahim, managing director of Cipla Australia.
    “Our sales representatives have already received some very enthusiastic and encouraging feedback from pharmacists, with them very eager to have wheezo on their shelves and more importantly in the hands of patients that need it.”

    wont be long and it will be flying of the shelves
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.005(6.33%)
Mkt cap ! $108.4M
Open High Low Value Volume
8.1¢ 8.5¢ 7.8¢ $67.37K 829.5K

Buyers (Bids)

No. Vol. Price($)
4 123417 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 95362 1
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.